Clinical trial
A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis
NCT00055133 · Angiotech Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00055133 |
|---|---|
| Title | A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis |
| Official title | A Phase 2 Open-Label Clinical Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis |
| Lead sponsor | Angiotech Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Micellar Paclitaxel for Injection |
| Enrollment | 50 |
| Start date | Sep 1, 2002 |
| Completion | Dec 1, 2004 |
| First posted | Feb 21, 2003 |
| Last update posted | Jul 29, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: